Skip to main content
×
Home
    • Aa
    • Aa

Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models

  • Gamal Ramadan (a1), Nadia M. El-Beih (a1) and Eman A. Abd El-Ghffar (a1)
Abstract

Cardiovascular complications are a major cause of morbidity and mortality in patients with diabetes, obesity and the metabolic syndrome. Recently, there has been an increasing interest in tea as a protective agent against CVD. Here, we compared the modulatory effects of two different doses (50 and 100 mg/kg body weight given orally for 28 consecutive days) of black tea aqueous extract (BTE, rich in theaflavins and thearubigins) and green tea aqueous extract (GTE, rich in catechins) on experimentally induced hyperglycaemia, hyperlipidaemia and liver dysfunction by alloxan (which destroys pancreatic β-cells and induces type 1 diabetes) and a cholesterol-rich diet (which induces obesity and type 2 diabetes) in male Wistar albino rats. Both tea extracts significantly alleviated most signs of the metabolic syndrome including hyperglycaemia (resulting from type 1 and 2 diabetes), dyslipidaemia and impairment of liver functions induced by alloxan or the cholesterol-rich diet in the animals. Also, the tea extracts significantly modulated both the severe decrease and increase in body weight induced by alloxan and the high-cholesterol diet, respectively. The modulatory effects obtained here were partial or complete, but significant and dose dependent, and slightly more in GTE in most cases. No harmful effects were detected for tea consumption on all parameters measured, except that the high dose of both tea extracts significantly decreased the spleen weight:body weight ratio and induced lymphopenia. The present study supports the hypothesis that both black and green teas may have beneficial effects against the risks of the metabolic syndrome and CVD as shown in rat models of human obesity and diabetes.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models
      Available formats
      ×
Copyright
Corresponding author
*Corresponding author: Dr Gamal Ramadan, fax +20 2 26842123, email gamal_ramadan@hotmail.com
References
Hide All
1 Lefebvre P (2005) Diabetes yesterday, today and tomorrow. The action of the International Diabetes Federation. Rev Med Liege 60, 273277.
2 Crespy V & Williamson G (2004) A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134, 3431S3440S.
3 Islam MS & Choi H (2007) Green tea, anti-diabetic or diabetogenic: a dose response study. Biofactors 29, 4553.
4 Murase T, Nagasawa A, Suzuki J, et al. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26, 14591464.
5 Rossner S (2002) Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 26, Suppl. 4, S2S4.
6 Lin JK & Lin-Shiau SY (2006) Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 50, 211217.
7 Bose M, Lambert JD, Ju J, et al. (2008) The major green tea polyphenol, ( − )-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 138, 16771683.
8 Anandh Babu PV, Sabitha KE & Shyamaladevi CS (2006) Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 33, 11841189.
9 Klaus S, Pultz S, Thone-Reineke C, et al. (2005) Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 29, 615623.
10 McKay DL & Blumberg JB (2007) Roles for epigallocatechin gallate in cardiovascular disease and obesity: an introduction. J Am Coll Nutr 26, 362S365S.
11 Yokozawa T, Nakagawa T & Kitani K (2002) Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 50, 35493552.
12 Chen H, Zhang M & Xie B (2005) Components and antioxidant activity of polysaccharide conjugate from green tea. Food Chem 90, 1721.
13 Cabrera C, Artacho R & Gimenez R (2006) Beneficial effects of green tea – a review. J Am Coll Nutr 25, 7999.
14 Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26, 373S388S.
15 Harbowy ME & Balentine DA (1997) Tea chemistry. Crit Rev Plant Sci 16, 415448.
16 Riemersma RA, Rice-Evans CA, Tyrrell RM, et al. (2001) Tea flavonoids and cardiovascular health. QJM 94, 277282.
17 Sabu MC, Smitha K & Kuttan R (2002) Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 83, 109116.
18 Das D, Mukherjee S, Mukherjee M, et al. (2005) Aqueous extract of black tea (Camellia sinensis) prevents chronic ethanol toxicity. Curr Sci 88, 952961.
19 Cooperstien SJ & Walkins D (1981) Action of toxic drugs on islet cells. In The Islets of Langerhans, pp. 387390 [Cooperstein SJ and Watkins D, editors]. New York: Academic Press.
20 Csont T, Balogh G, Csonka C, et al. (2002) Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. Biochem Biophys Res Commun 290, 15351538.
21 Onody A, Csonka C, Giricz Z, et al. (2003) Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58, 663670.
22 Trinder P (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6, 2427.
23 Frings CS & Dunn RT (1970) A colorimetric method for determination of total serum lipids based on the sulfo-phospho-vanillin reaction. Am J Clin Pathol 53, 8991.
24 Doumas BT, Watson WA & Biggs HG (1971) Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31, 8796.
25 Allain CC, Poon LS, Chan CS, et al. (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20, 470475.
26 Vikari J (1976) Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 36, 265268.
27 Takayama M, Itoh S, Nagasaki T, et al. (1977) A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79, 9398.
28 Doumas BT, Bayse DD, Carter RJ, et al. (1981) A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem 27, 16421650.
29 McGowan MW, Artiss JD, Strandbergh DR, et al. (1983) A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29, 538542.
30 Trinder P & Webster D (1984) Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem 21, 430433.
31 Fossati P, Ponti M, Prencipe L, et al. (1989) One-step protocol for assays of total and direct bilirubin with stable combined reagents. Clin Chem 35, 173176.
32 Reitman S & Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28, 5663.
33 Tietz NW, Burtis CA, Duncan P, et al. (1983) A reference method for measurement of alkaline phosphatase activity in human serum. Clin Chem 29, 751761.
34 Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499502.
35 Turner JR & Thayer JF (editors) (2001) Introduction to Analysis of Variance: Design, Analysis and Interpretation. Thousand Oaks, CA: Sage Publications.
36 Moram GS (2001) Effect of aqueous extracts from some plants on alloxan – diabetic rats. Egypt J Hosp Med 2, 5769.
37 Ene AC, Nwankwo EA & Samdi LM (2007) Alloxan-induced diabetes in rats and the effects of black caraway (Carum carvi L.) oil on their body weight. Res J Med Med Sci 2, 4852.
38 Czako L, Szabolcs A, Vajda A, et al. (2007) Hyperlipidemia induced by a cholesterol-rich diet aggravates necrotizing pancreatitis in rats. Eur J Pharmacol 572, 7481.
39 Butler J, Rodondi N, Zhu Y, et al. (2006) Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 47, 15951602.
40 Knuiman MW, Hung J, Divitini ML, et al. (2009) Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil 16, Suppl. 2, 235241.
41 Thorn LM, Forsblom C, Waden J, et al. (2009) Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 32, Suppl. 5, 950952.
42 Shimizu M, Kobayashi Y, Suzuki M, et al. (2000) Regulation of intestinal glucose transport by tea catechins. Biofactors 13, 6165.
43 Kim MJ, Ryu GR, Chung JS, et al. (2003) Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26, 292299.
44 Janle EM, Portocarrero C, Zhu Y, et al. (2005) Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats. J Herb Pharmacother 5, 5565.
45 Zhou X, Wang D, Sun P, et al. (2007) Effects of soluble tea polysaccharides on hyperglycemia in alloxan-diabetic mice. J Agric Food Chem 55, 55235528.
46 Waltner-Law ME, Wang XL, Law BK, et al. (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 3493334940.
47 Chemler JA, Lock LT, Koffas MA, et al. (2007) Standardized biosynthesis of flavan-3-ols with effects on pancreatic β-cell insulin secretion. Appl Microbiol Biotechnol 77, 797807.
48 Wolfram S, Raederstorff D, Preller M, et al. (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 25122518.
49 Kuo KL, Weng MS, Chiang CT, et al. (2005) Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats. J Agric Food Chem 53, 480489.
50 Matsumoto N, Okushio K & Hara Y (1998) Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo) 44, Suppl. 2, 337342.
51 Yang TT & Koo MW (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66, 411423.
52 Bursill CA, Abbey M & Roach PD (2007) A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 193, 8693.
53 Lin CL, Huang HC & Lin JK (2007) Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res 48, 23342343.
54 Oyejide OO & Olushola L (2005) Hepatoprotective and antioxidant properties of extract of Carmellia sinensis (black tea) in rats. Afr J Biotechnol 4, 14321438.
55 Raederstorff DG, Schlachter MF, Elste V, et al. (2003) Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14, 326332.
56 Koo SI & Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18, 179183.
57 Chan PT, Fong WP, Cheung YL, et al. (1999) Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr 129, 10941101.
58 Yee WL, Wang Q, Agdinaoay T, et al. (2002) Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol Cell Biochem 229, 8592.
59 Balentine DA, Wiseman SA & Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693704.
60 Keith RP, Michael JCR & Karen AB (1998) Flavonol glycoside content and composition of tea infusions made from commercially available teas and tea products. J Agric Food Chem 46, Suppl. 7, 25172522.
61 Leung LK, Su Y, Chen R, et al. (2001) Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr 131, 22482251.
62 Taylor EB, Ellingson WJ, Lamb JD, et al. (2005) Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. Am J Physiol Endocrinol Metab 288, E1055E1061.
63 Murase T, Misawa K, Haramizu S, et al. (2009) Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol 78, 7884.
64 Lin CL & Lin JK (2008) Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res 52, 930939.
65 Steele VE, Kelloff GJ, Balentine D, et al. (2000) Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 21, 6367.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 12
Total number of PDF views: 104 *
Loading metrics...

Abstract views

Total abstract views: 162 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.